Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Blood Advances|September 23, 2021
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemiaIng S Tiong, Richard Dillon, Adam Ivey, et al.
Blood Cancer Journal|April 11, 2023
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasmsMithun Vinod Shah, Elizabeth Ngoc Hoa Tran, Syed Shah, et al.
Blood|December 19, 2014
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsDavid T Yeung, Michael P Osborn, Deborah L White, et al.
Blood|March 8, 2024
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activationLih En Hong, Mihir D Wechalekar, Monika Kutyna, et al.
Leukemia|April 14, 2021
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancerDeepak Singhal, Christopher N Hahn, Simone Feurstein, et al.
Blood Advances|February 1, 2023
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AMLStéphane de Botton, Pierre Fenaux, Karen Yee, et al.
Leukemia|May 16, 2019
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distributionDeepak Singhal, Li Yan A Wee, Monika M Kutyna, et al.
Blood Advances|March 14, 2025
Factors associated with survival following allogeneic transplantation for myeloid neoplasms harboring TP53 mutationsAnmol Baranwal, Kimberly Langer, Vedavyas Gannamani, et al.
Blood|August 30, 2023
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLGSun Loo, Andrew W Roberts, Natasha S Anstee, et al.
Blood Advances|March 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutationsMithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Pageof 5